Subsequently, we performed western blot validation on COX-2/PGE2/EP4 pathway-related proteins in different tumor cells and found that the key enzyme COX-2 was highly expressed in gastric cancer, leading to abnormal pathway activation (Fig. S1A). This evidence concerns the gene PTGER4 and neoplasm.